Related Experiment Video
Updated: Oct 20, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Emerging Therapies in the Treatment of Advanced Melanoma
Sameer Massand1, Rogerio I Neves2
1Division of Plastic Surgery, Penn State University, 500 University Drive, H071, Hershey, PA 17033, USA.
Abstract:
Great strides in immunotherapy and targeted therapy have revolutionized the management of previously devastating, advanced melanomas. Although these subfields continue to progress, novel approaches in intratumoral oncolytic therapy, adoptive cell therapy, and vaccine therapies are being developed as adjuncts or alternatives. Cytokines, meanwhile, are seeing a resurgence as a viable option as well. The array of effective agents will, in the next few years, provide options for therapy not only in the adjuvant or unresectable settings but also in the neoadjuvant settings. Perhaps, too, in earlier stage melanomas.
Insights
Advances in melanoma treatment, including immunotherapy and targeted therapy, are offering new hope. Emerging strategies like oncolytic therapy, cell therapies, and vaccines are expanding treatment options for advanced and earlier-stage melanomas.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Advanced melanomas were historically devastating with limited treatment options.
- Immunotherapy and targeted therapy have significantly improved outcomes for advanced melanoma.
- Continued research is essential to overcome treatment resistance and improve patient survival.
Purpose of the Study:
- To review recent advancements in melanoma treatment.
- To highlight emerging therapeutic strategies beyond current standards of care.
- To discuss the potential application of novel therapies in various stages of melanoma.
Main Methods:
- Review of current literature on melanoma treatment.
- Analysis of emerging therapeutic modalities.
- Discussion of clinical trial outcomes and future directions.
Main Results:
- Immunotherapy and targeted therapy have revolutionized melanoma management.
- Novel approaches including oncolytic therapy, adoptive cell therapy, and vaccines are under development.
- Cytokines are regaining prominence as a therapeutic option.
- These agents are expected to offer neoadjuvant and adjuvant treatment options for various melanoma stages.
Conclusions:
- The therapeutic landscape for melanoma is rapidly evolving with promising new options.
- Future treatment strategies will likely involve a combination of established and novel approaches.
- These advancements hold the potential to improve outcomes even in earlier-stage melanomas.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

